Virginia Commonwealth University Medical Center Incorrectly Billed Medicare for the Biological Drug Myozyme
External Quality Review of Dialysis Facilities Two Promising Approaches
Indiana Reduced Medicaid Costs for Home Blood-Glucose Test Strips by Approximately 50 Percent Using Manufacturer Rebates
External Quality Review of Dialysis Facilities A Call For Greater Accountability
AdminaStar Federal, Inc., Claimed Some Unallowable Supplemental Executive Retirement Plan Costs for Medicare Reimbursement for Fiscal Years 2004 Through 2006
Problems Pervade the Renal Beneficiary and Utilization System
Audit of Palmetto GBA's Railroad Retirement Board Final Administrative Cost Proposals for Fiscal Years 2007 and 2008
Clinical Performance Measures for Dialysis Facilities Lessons Learned by the Major Dialysis Corporations and Implications for Medicare Supplemental Report # 2
401(k) Costs Claimed by Blue Cross Blue Shield of Tennessee for Fiscal Years 2005 Through 2009 Were Reasonable and Allowable
Retirement Accumulation Program Costs Claimed by Blue Cross Blue Shield of Tennessee for Fiscal Years 2008 and 2009 Were Reasonable and Allowable
Clinical Performance Measures for Dialysis Facilities
Review of Medicare Payments Exceeding Charges for Outpatient Services Processed by Wisconsin Physicians Service Insurance Corporation in Jurisdiction 5 for the Period January 1, 2006, Through June 30, 2009
Maine Did Not Always Make Correct Medicaid Claim Adjustments
Home Dialysis Payment Vulnerabilities
Pennsylvania Claimed Medicaid Administrative Costs for Provider Training Under Its Restraint Reduction Initiative
AVAILABILITY OF QUALITY OF CARE DATA IN THE MEDICARE END STAGE RENAL DISEASE PROGRAM
Not All of Colorado's Claimed State Children's Health Insurance Program Expenditures Were Allowable
Nevada Improperly Claimed Federal Reimbursement for Medicare Part B Premiums Paid on Behalf of Medicaid Beneficiaries
MEDICARE REIMBURSEMENT FOR END STAGE RENAL DISEASE DRUGS: THIRD QUARTER 2006
Ashtabula County Medical Center Incorrectly Billed Medicare for Leuprolide Acetate Implants